Endocrinología

Artículos Científicos

• García-Soidán JL, Pérez-Ribao I, Leirós-Rodríguez R, Soto-Rodríguez A. Long-Term Influence of the Practice of Physical Activity on the Self-Perceived Quality of Life of Women with Breast Cancer: A Randomized Controlled Trial. Int J Environ Res Public Health. 2020 Jul;17(14) PMID: 32664375. DOI: 10.3390/ijerph17144986. +Pubmed +DOI

Artículos Científicos

• Donnay Candil S, Oleaga Alday A, Álvarez-García E. Reference TSH levels in Spanish pregnant women. Is it possible to unify criteria? Endocrinol diabetes y Nutr. 2019 Feb;66(2):124–31. PMID: 30552019. DOI: 10.1016/j.endinu.2018.09.007. +Pubmed +DOI
• Fandiño J, Toba L, González-Matías LC, Diz-Chaves Y, Mallo F. Perinatal Undernutrition, Metabolic Hormones, and Lung Development. Nutrients. 2019 Nov;11(12):2870. PMID: 31771174. DOI: 10.3390/nu11122870. +Pubmed +DOI

Artículos Científicos

• Diz-Chaves Y, Toba L, Fandiño J, González-Matías LC, Garcia-Segura LM, Mallo F. The GLP-1 analog, liraglutide prevents the increase of proinflammatory mediators in the hippocampus of male rat pups submitted to maternal perinatal food restriction. J Neuroinflammation. 2018 Dec;15(1):337. PMID: 30518432. DOI: 10.1186/s12974-018-1370-7. +Pubmed +DOI
• Fandiño J, Vaz AA, Toba L, Romaní-Pérez M, González-Matías L, Mallo F, Diz-Chaves Y. Liraglutide Enhances the Activity of the ACE-2/Ang(1-7)/Mas Receptor Pathway in Lungs of Male Pups from Food-Restricted Mothers and Prevents the Reduction of SP-A. Int J Endocrinol. 2018;2018:6920620. PMID: 30627159. DOI: 10.1155/2018/6920620. +Pubmed +DOI
• Salgado-Freiría R, López-Doval S, Lafuente A. Perfluorooctane sulfonate (PFOS) can alter the hypothalamic-pituitary-adrenal (HPA) axis activity by modifying CRF1 and glucocorticoid receptors. Toxicol Lett. 2018 Oct;295:1–9. PMID: 29807116. DOI: 10.1016/j.toxlet.2018.05.025. +Pubmed +DOI
• Soto Rodríguez A, García Soidán JL, Arias Gómez MJ, Del Álamo Alonso A, Leirós Rodríguez R, Pérez Fernández MR. Educational intervention on cardiovascular parameters in perimenopausal women with a cardiovascular risk factor. Randomised clinical trial. Med Clin (Barc). 2018 Mar;150(5):178–84. PMID: 28743399. DOI: 10.1016/j.medcli.2017.06.020. +Pubmed +DOI

Artículos Científicos

• Garcia-Mayor R V, Garcia-Soidan FJ, García-Mayor R V, García-Soidán FJ. Eating disoders in type 2 diabetic people: Brief review. Diabetes Metab Syndr Clin Res Rev. 2017 Jul;11(3):221–4. PMID: 27575047. DOI: 10.1016/j.dsx.2016.08.004. IF2017: N/A. +Pubmed +DOI
• García-Soidán FJ, Villoro R, Merino M, Hidalgo-Vega Á, Hernando-Martín T, González-Martín-Moro B. [Health status, quality of life, and use of healthcare resources by patients with diabetes mellitus in Spain]. Semergen. 2017 Sep;43(6):416–24. PMID: 27445223. DOI: 10.1016/j.semerg.2016.06.004. IF2017: N/A. +Pubmed +DOI
• Soto Rodríguez A, García Soidán JL, Arias Gómez MJ, Leirós Rodríguez R, Del Álamo Alonso A, Pérez Fernández MR. [Metabolic syndrome and visceral fat in women with cardiovascular risk factor]. Nutr Hosp. 2017 Jul;34(4):863–8. PMID: 29095010. DOI: 10.20960/nh.1085. IF2017: 0.845; Q4. +Pubmed +DOI
• Soto-Rodríguez A, García-Soidán JL, de Toro-Santos M, Rodríguez-González M, Arias-Gómez MJ, Pérez-Fernández MR. [Clinical trial with educational intervention in perimenopausal women with cardiovascular risk factor]. Gac Sanit. 2017 Jan;31(1):48–52. PMID: 27793547. DOI: 10.1016/j.gaceta.2016.07.022. IF2017: 1.581; Q3. +Pubmed +DOI
• Vázquez-Iglesias L, Casado-Rey P, Botana-Rial M, Andrade-Olivié MA, Rodriguez-Berrocal FJ, Páez de la Cadena M, Fernández-Villar A. Evaluation of an automated commercial ELISA method for calprotectin determination in pleural fluid. Clin Chem Lab Med. 2017 Jul;55(8):e172–4. PMID: 27898399. DOI: 10.1515/cclm-2016-0884. IF2017: 3.556; Q1. +Pubmed +DOI

Guías de Práctica Clínica

• Garcia-Soidan FJ, Malo García F, López Alvarez-Muiño XL, Martínez Vidal Á, Plana Pintos R, Modroño Freire MJ, Gestoso Lamazares T, Paramio Castedo F, Conde Guede L, López Pereiro O. Fisterra Guías Clínicas: Diabetes Melllitus tipo 2. Fisterra; 2017. https://www.fisterra.com/guias-clinicas/diabetes-mellitus-tipo-2/#26610 Enlace
• Garcia-Soidan FJ. Fisterra Guías Clínicas: Manejo de insulina en personas con diabetes tipo 2. 2017. https://www.fisterra.com/guias-clinicas/manejo-insulina-diabetes-tipo-2/#26567 Enlace

Artículos Científicos

• Diz-Chaves Y, Gil-Lozano M, Toba L, Fandiño J, Ogando H, González-Matías LC, Mallo F. Stressing diabetes? The hidden links between insulinotropic peptides and the HPA axis. J Endocrinol. 2016 Aug;230(2):R77-94. PMID: 27325244. DOI: 10.1530/JOE-16-0118. IF2016: 4.706; Q1. +Pubmed +DOI
• Fornos-Pérez JA, Andrés-Rodríguez NF, Andrés-Iglesias JC, Luna-Cano R, García-Soidán J, Lorenzo-Veiga B, Mera-Gallego R, García-Riestra R. Detection of people at risk of diabetes in community pharmacies of Pontevedra (Spain) (DEDIPO). Endocrinol Nutr. 2016 Oct;63(8):387–96. PMID: 27481442. DOI: 10.1016/j.endonu.2016.06.002. IF2016: 1.106; Q4. +Pubmed +DOI
• López-Doval S, Salgado R, Lafuente A. The expression of several reproductive hormone receptors can be modified by perfluorooctane sulfonate (PFOS) in adult male rats. Chemosphere. 2016 Jul;155:488–97. PMID: 27151425. DOI: 10.1016/j.chemosphere.2016.04.081. IF2016: 4.208; Q1. +Pubmed +DOI
• Salgado R, López-Doval S, Pereiro N, Lafuente A. Perfluorooctane sulfonate (PFOS) exposure could modify the dopaminergic system in several limbic brain regions. Toxicol Lett. 2016 Jan;240(1):226–35. PMID: 26529483. DOI: 10.1016/j.toxlet.2015.10.023. IF2016: 3.087; Q1. +Pubmed +DOI
• Salinas M, López-Garrigós M, Flores E, Uris J, Leiva-Salinas C, REDCONLAB working group (MA Andrade-Olivié). Potential risk for inappropriate dyslipidemia screening in Primary Care in Spain. Rev del Lab Clínico. 2016 Apr;9(2):48–53. DOI: 10.1016/j.labcli.2016.04.001. IF2016: N/A. +DOI
• Salinas M, López-Garrigós M, Pomares FJ, Flores E, Uris J, Leiva-Salinas C, REDCONLAB (MA Andrade-Olivié). Solicitud de pruebas de función tiroidea desde Atención Primaria en España. Endocrinol y Nutr. 2016 Jan;63(1):19–26. DOI: 10.1016/j.endonu.2015.06.011. IF2016: 1.106; Q4. +DOI
• Sánchez Sobrino P, Páramo Fernández C, Martínez Cueto P. Fahr´s syndrome. Rev Clin Esp. 2016 Oct;216(7):400–1. PMID: 27086479. DOI: 10.1016/j.rce.2016.03.002. IF2016: 0.971; Q3. +Pubmed +DOI
• Soto Rodríguez A, García Soidán JL, de Toro Santos M, Lagoa Labrador F, Failde Garrido JM, Pérez Fernández MR. [Benefits of an educational intervention on diet and anthropometric profile of women with one cardiovascular risk factor]. Med Clin (Barc). 2016 May;146(10):436–9. PMID: 26897504. DOI: 10.1016/j.medcli.2015.12.013. IF2016: 1.125; Q3. +Pubmed +DOI

Artículos Científicos

• López-Doval S, Salgado R, Fernández-Pérez B, Lafuente A. Possible role of serotonin and neuropeptide Y on the disruption of the reproductive axis activity by perfluorooctane sulfonate. Toxicol Lett. 2015 Mar;233(2):138–47. PMID: 25623392. DOI: 10.1016/j.toxlet.2015.01.012. IF2015: 3.522; Q1. +Pubmed +DOI
• Lu B, Diz-Chaves Y, Markovic D, Contarino A, Penicaud L, Fanelli F, Clark S, Lehnert H, Cota D, Grammatopoulos DK, Tabarin A. The corticotrophin-releasing factor/urocortin system regulates white fat browning in mice through paracrine mechanisms. Int J Obes (Lond). 2015 Mar;39(3):408–17. PMID: 25189177. DOI: 10.1038/ijo.2014.164. IF2015: 5.337; D1. +Pubmed +DOI
• Outeiriño-Iglesias V, Romaní-Pérez M, González-Matías LC, Vigo E, Mallo F. GLP-1 Increases Preovulatory LH Source and the Number of Mature Follicles, As Well As Synchronizing the Onset of Puberty in Female Rats. Endocrinology. 2015 Nov;156(11):4226–37. PMID: 26252058. DOI: 10.1210/en.2014-1978. IF2015: 4.159; Q1. +Pubmed +DOI
• Romaní-Pérez M, Outeiriño-Iglesias V, Moya CM, Santisteban P, González-Matías LC, Vigo E, Mallo F. Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats. Endocrinology. 2015 Oct;156(10):3559–69. PMID: 26196539. DOI: 10.1210/en.2014-1685. IF2015: 4.159; Q1. +Pubmed +DOI
• Salgado R, Pereiro N, López-Doval S, Lafuente A. Initial study on the possible mechanisms involved in the effects of high doses of perfluorooctane sulfonate (PFOS) on prolactin secretion. Food Chem Toxicol. 2015 Sep;83:10–6. PMID: 26032630. DOI: 10.1016/j.fct.2015.05.013. IF2015: 3.584; Q1. +Pubmed +DOI

Artículos Científicos

• Gil-Lozano M, Romaní-Pérez M, Outeiriño-Iglesias V, Vigo E, González-Matías LC, Brubaker PL, Mallo F. Corticotropin-releasing hormone and the sympathoadrenal system are major mediators in the effects of peripherally administered exendin-4 on the hypothalamic-pituitary-adrenal axis of male rats. Endocrinology. 2014 Jul;155(7):2511–23. PMID: 24731096. DOI: 10.1210/en.2013-1718. IF: 4.503; Q1. +Pubmed +DOI
• López-Doval S, Salgado R, Pereiro N, Moyano R, Lafuente A. Perfluorooctane sulfonate effects on the reproductive axis in adult male rats. Environ Res. 2014 Oct;134:158–68. PMID: 25171141. DOI: 10.1016/j.envres.2014.07.006. IF: 1.350; Q1. +Pubmed +DOI
• Pereiro N, Moyano R, Blanco A, Lafuente A. Regulation of corticosterone secretion is modified by PFOS exposure at different levels of the hypothalamic-pituitary-adrenal axis in adult male rats. Toxicol Lett. 2014 Oct;230(2):252–62. PMID: 24440345. DOI: 10.1016/j.toxlet.2014.01.003. IF: 3.262; Q1. +Pubmed +DOI